BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25664503)

  • 1. Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.
    Bjarnason A; Asgeirsson H; Baldursson O; Kristinsson KG; Gottfredsson M
    Infect Dis (Lond); 2015 Mar; 47(3):130-6. PubMed ID: 25664503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
    Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
    Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].
    Taşbakan MS; Bacakoğlu F; Başoğlu OK; Gürgün A; Başarik B; Citim Tuncel S; Sayiner A
    Tuberk Toraks; 2011; 59(4):348-54. PubMed ID: 22233304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
    Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
    Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.
    Umeki K; Tokimatsu I; Yasuda C; Iwata A; Yoshioka D; Ishii H; Shirai R; Kishi K; Hiramatsu K; Matsumoto B; Kadota J
    Respirology; 2011 Jul; 16(5):856-61. PubMed ID: 21545370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
    Falcone M; Venditti M; Shindo Y; Kollef MH
    Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
    Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
    Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
    J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.
    Vallés J; Martin-Loeches I; Torres A; Diaz E; Seijas I; López MJ; Garro P; Castillo C; Garnacho-Montero J; Martin Mdel M; de la Torre MV; Olaechea P; Cilloniz C; Almirall J; García F; Jiménez R; Seoane E; Soriano C; Mesalles E; Posada P
    Intensive Care Med; 2014 Apr; 40(4):572-81. PubMed ID: 24638939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
    Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
    Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
    Hyun H; Song JY; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
    PLoS One; 2022; 17(6):e0270261. PubMed ID: 35767562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the patients with community-acquired pneumonia (CAP) and health care-associated pneumonia (HCAP) requiring hospitalization.
    Kara S; Akçay MŞ; Ekici Ünsal Z; Bozkurt Yılmaz HE; Habeşoğlu MA
    Tuberk Toraks; 2019 Jun; 67(2):108-115. PubMed ID: 31414641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcome of healthcare associated pneumonia in Turkey.
    Gündüz C; Taşbakan MS; Sayıner A; Çilli A; Kılınç O; Şakar Coşkun A
    Tuberk Toraks; 2016 Sep; 64(3):185-190. PubMed ID: 28393724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
    Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
    J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
    Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
    Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of patients with hemodialysis-associated pneumonia compared to patients with non-hemodialysis community-onset pneumonia.
    Lee JH; Moon JC
    Respir Med; 2016 Feb; 111():84-90. PubMed ID: 26777263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.